Corcept Therapeutics CORT
NASDAQ CORT
$114.74 -0.89 (-0.77%)
At close: Sep 29, 2026 · 4:00 PM EDT

Corcept Therapeutics (CORT) Net Margin (2012 - 2026)

Updated

Corcept Therapeutics (CORT) posted Net Margin of 16.45% for Q2 2026, down 1.35 percentage points from 17.80% a year earlier but up 35.37 percentage points from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Net Margin (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Margin at Corcept Therapeutics was 6.52%, down 11.91 percentage points year-over-year; for FY2025, it came in at 12.89%, down 7.81 percentage points from FY2024.

  • Annual Net Margin has declined for four consecutive years, with a five-year change of -17.06 percentage points (FY2020 to FY2025).
  • In prior years, Corcept Therapeutics' Net Margin was 20.70% in FY2024 (-1.17 pp), 21.87% in FY2023 (-3.33 pp), 25.20% in FY2022 (-5.54 pp) and 30.74% in FY2021 (+0.79 pp).
  • Quarterly Net Margin has run from a low of -18.92% in Q1 2026 to a high of 33.96% in Q3 2022 over five years.
  • On a year-over-year basis, Net Margin has declined in each of the last seven quarters, with an average year-over-year change of -8.72 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Net Margin in the past five years was Q4 2023, with a gain of 6.96 percentage points; the weakest was Q1 2026, with a drop of 31.83 percentage points.
  • According to Business Quant data, Net Margin for the three prior quarters was -18.92% (Q1 2026), 11.83% (Q4 2025) and 9.32% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 Corcept Therapeutics 12.50 Bn 11.06 Bn 252.09 Mn 16.45%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.45%
Mar 31, 2026 -18.92%
Dec 31, 2025 11.83%
Sep 30, 2025 9.32%
Jun 30, 2025 17.80%
Mar 31, 2025 12.90%
Dec 31, 2024 16.71%
Sep 30, 2024 25.58%
Jun 30, 2024 21.44%
Mar 31, 2024 18.74%
Dec 31, 2023 23.00%
Sep 30, 2023 25.22%
Jun 30, 2023 23.24%
Mar 31, 2023 14.96%
Dec 31, 2022 16.04%
Sep 30, 2022 33.96%
Jun 30, 2022 26.50%
Mar 31, 2022 24.33%
Dec 31, 2021 32.44%
Sep 30, 2021 31.70%
API Access

Corcept Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=CORT&period=max&api_key=YOUR_API_KEY